Respiratory syncytial virus (RSV) is the second most common pathogen causing infant mortality. Additionally, RSV is a major cause of morbidity and mortality in older adults (age ≥60 years) similar to influenza. A protein-based maternal vaccine and mono...
Vaccination has been shown to be the most effective means of preventing infectious diseases, although older people commonly have a suboptimal immune response to vaccines and thus impaired protection against subsequent adverse outcomes. This Review prov...
The global health community has had more than a decade to develop pandemic preparedness programmes and apply lessons learnt to new disease outbreaks. Mpox has now been declared a global public health emergency, but the response appears to be missing im...
Since 2018, WHO experts have annually brought attention to the poor quality of care for children at risk of developing active tuberculosis or with tuberculosis disease around the world.1,2 Estimates show that about 67 million children with latent tuber...
The three years when infections causd by SARS-CoV-2 were considered a global emergency are arguably still felt beyond WHO's ‘non-emergent’ declaration. The global nature of this emergency drastically changed the way people, companies, and governments w...
Whelan MG, Ware H, Ranka H, et al. ArboTracker: a multipathogen dashboard and data platform for arbovirus seroprevalence studies. Lancet Infect Dis 2024; published online Sept 10. https://doi.org/10.1016/S1473-3099(24)00585-1—In this Correspondence, Sh...
High rates of microbiological confirmation of tuberculosis in children can be achieved via parallel sampling and concurrent testing procedures. Sample types and choice of test to be used sequentially should be considered when applying to groups such as...
No other service loses as much money as the infectious disease clinical service in hospitals. Infectious disease consultations have lower reimbursement rates compared with other types of consultations. The precarious financing of infectious diseases is...
In 2019, WHO highlighted vaccine hesitancy as a major global health threat, exacerbated by anti-vaccination movements and social media. Defined as ‘reluctance or refusal to have oneself or one's children vaccinated against infectious disease’, vaccine ...
Our results suggest that MDPPF can help prevent dengue under the many operational constraints of real-world vector-control interventions and despite incomplete coverage and potential dilution of intervention effects. MDPPF holds promise as an additiona...
In The Lancet Infectious Diseases, Fernando Abad-Franch and colleagues1 present the results of a study that used distributions in case data to assess the effect of mosquito-disseminated pyriproxyfen to control dengue virus in Belo Horizonte, Brazil.
Adaptations to sexual behaviour due to mpox were widespread, dynamic, and responded to evolving individual risk perceptions. We propose that the decline in mpox transmission seen at the end of 2022 resulted primarily from a combination of behavioural a...
Adaptations to sexual behaviour due to mpox were widespread, dynamic, and responded to evolving individual risk perceptions. We propose that the decline in mpox transmission seen at the end of 2022 resulted primarily from a combination of behavioural a...
On Aug 13, 2024, the Africa Centres for Disease Control and Prevention declared mpox a Public Health Emergency of Continental Security in Africa. The following day, mpox was declared a Public Health Emergency of International Concern by WHO.1 The trans...
Patients infected with antifungal-resistant fungi often do not respond to therapy, substantially increasing mortality risk. Some fungi are inherently resistant to particular antifungals, underscoring the importance of rapid genus identification or, ide...
Patients infected with antifungal-resistant fungi often do not respond to therapy, substantially increasing mortality risk. Some fungi are inherently resistant to particular antifungals, underscoring the importance of rapid genus identification or, ide...